Price $87.24 |
Market Cap
39.74B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.7
|
P/B
6.12
|
P/S
7.0
|
Dividend %
-
|
|
P/CF
245.0
|
P/FCF
50.7
|
Op. Cash Flow
1.04M
|
FCF
1.3
|
|
Op. Margin
27.20%
|
Net Margin
24.60%
|
ROE
23.10%
|
ROI
23.50%
|
|
ROA
16.20%
|
EPS Growth
0.20%
|
Current Ratio
3.0
|
Debt/Equity
10.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $15.33 | - | - | 197.4M | Strong Buy |
| Nabriva Therapeutics PLC - ADR (NBRVF) | $0.00 | - | - | 1.7M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.04 | - | - | 5M | Strong Buy |
| Myomo Inc (MYO) | $2.72 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.10 | - | - | 8.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
